000			02142 a2200589 4500
005			20250513090130.0
264		0	_c19960604
008			199606s 0 0 eng d
022			_a0007-0920
024	7		_a10.1038/bjc.1996.138 _2doi
040			_aNLM _beng _cNLM
100	1		_aBrugnatelli, S
245	0	0	_aExperience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma. _h[electronic resource]
260			_bBritish journal of cancer _cMar 1996
300			_a794-7 p. _bdigital
500			_aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAntineoplastic Agents, Alkylating _xadministration & dosage
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aEpirubicin _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aInterferon alpha-2
650	0	4	_aInterferon-alpha _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMelphalan _xadministration & dosage
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Myeloma _xdrug therapy
650	0	4	_aMyeloproliferative Disorders _xchemically induced
650	0	4	_aPeptichemio _xadministration & dosage
650	0	4	_aPrednisone _xadministration & dosage
650	0	4	_aRecombinant Proteins
650	0	4	_aVincristine _xadministration & dosage
700	1		_aRiccardi, A
700	1		_aUcci, G
700	1		_aMora, O
700	1		_aBarbarano, L
700	1		_aPiva, N
700	1		_aPiccinini, L
700	1		_aBergonzi, C
700	1		_aDe Paoli, A
700	1		_aDi Stasi, M
700	1		_aRinaldi, E
700	1		_aTrotti, G
700	1		_aPetrini, M
700	1		_aAscari, E
773	0		_tBritish journal of cancer _gvol. 73 _gno. 6 _gp. 794-7
856	4	0	_uhttps://doi.org/10.1038/bjc.1996.138 _zAvailable from publisher's website
999			_c8610429 _d8610429